small molecule therapeutic for degenerative arthritis (Beijing Orbiepharmacy Technology)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule therapeutic for degenerative arthritis (Beijing Orbiepharmacy Technology)
Drug Alias Nameorbicoxiboubixibu
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Orbiepharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Orbiepharm Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A